Open Access Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-In

Zuk, Anna; Si, Zhihai; Loi, Sally; Bommegowda, Santhosh; Hoivik, Debie; Danthi, Sanjay; Molnar, Gyongyi; Csizmadia, Vilmos; Rabinowitz, Michael

doi:10.1124/jpet.122.001126

Open Access Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-In

Journal Article · 01 October 2022 · J. Pharmacol. Exp. Ther.

DOI:https://doi.org/10.1124/jpet.122.001126· OSTI ID:1901069

Zuk, Anna; Si, Zhihai; Loi, Sally; Bommegowda, Santhosh; Hoivik, Debie; Danthi, Sanjay; Molnar, Gyongyi; Csizmadia, Vilmos; Rabinowitz, Michael

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1901069

Journal Information:: J. Pharmacol. Exp. Ther., Vol. 383, Issue (1)

Country of Publication:: United States

Language:: ENGLISH

References (55)

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis Akizawa, Tadao; Yamada, Takashi; Nobori, Kiyoshi Kidney International Reports, Vol. 6, Issue 10 https://doi.org/10.1016/j.ekir.2021.07.015	journal	October 2021
A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial Akizawa, Tadao; Nangaku, Masaomi; Yamaguchi, Takuhiro American Journal of Nephrology, Vol. 49, Issue 2 https://doi.org/10.1159/000496929	journal	January 2019
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor Appelhoff, Rebecca J.; Tian, Ya-Min; Raval, Raju R. Journal of Biological Chemistry, Vol. 279, Issue 37 https://doi.org/10.1074/jbc.M406026200	journal	September 2004
Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia Ariazi, Jennifer L.; Duffy, Kevin J.; Adams, David F. Journal of Pharmacology and Experimental Therapeutics, Vol. 363, Issue 3 https://doi.org/10.1124/jpet.117.242503	journal	September 2017
Mechanisms of Anemia in CKD Babitt, Jodie L.; Lin, Herbert Y. Journal of the American Society of Nephrology, Vol. 23, Issue 10 https://doi.org/10.1681/ASN.2011111078	journal	August 2012
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Barrett, Terrance D.; Palomino, Heather L.; Brondstetter, Theresa I. Molecular Pharmacology, Vol. 79, Issue 6 https://doi.org/10.1124/mol.110.070508	journal	March 2011
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1 in normoxia Berra, E. The EMBO Journal, Vol. 22, Issue 16 https://doi.org/10.1093/emboj/cdg392	journal	August 2003
A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial Brigandi, Richard A.; Johnson, Brendan; Oei, Coreen American Journal of Kidney Diseases, Vol. 67, Issue 6 https://doi.org/10.1053/j.ajkd.2015.11.021	journal	June 2016
Mitochondrial energetics in the kidney Bhargava, Pallavi; Schnellmann, Rick G. Nature Reviews Nephrology, Vol. 13, Issue 10 https://doi.org/10.1038/nrneph.2017.107	journal	August 2017
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration Broxmeyer, Hal E. Journal of Experimental Medicine, Vol. 210, Issue 2 https://doi.org/10.1084/jem.20122760	journal	February 2013
DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys Chang, Yu-Ting; Yang, Ching-Chin; Pan, Szu-Yu Journal of Clinical Investigation, Vol. 126, Issue 2 https://doi.org/10.1172/JCI82819	journal	January 2016
Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD Chertow, Glenn M.; Pergola, Pablo E.; Farag, Youssef M. K. New England Journal of Medicine, Vol. 384, Issue 17 https://doi.org/10.1056/NEJMoa2035938	journal	April 2021
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease del Balzo, Ughetta; Signore, Pierre E.; Walkinshaw, Gail Journal of Pharmacology and Experimental Therapeutics, Vol. 374, Issue 2 https://doi.org/10.1124/jpet.120.265181	journal	June 2020
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis Eckardt, Kai-Uwe; Agarwal, Rajiv; Aswad, Ahmad New England Journal of Medicine, Vol. 384, Issue 17 https://doi.org/10.1056/NEJMoa2025956	journal	April 2021
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation Epstein, Andrew C. R.; Gleadle, Jonathan M.; McNeill, Luke A. Cell, Vol. 107, Issue 1 https://doi.org/10.1016/S0092-8674(01)00507-4	journal	October 2001
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin Eschbach, Joseph W. Kidney International, Vol. 35, Issue 1 https://doi.org/10.1038/ki.1989.18	journal	January 1989
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study Fishbane, Steven; El-Shahawy, Mohamed A.; Pecoits-Filho, Roberto Journal of the American Society of Nephrology, Vol. 32, Issue 3 https://doi.org/10.1681/ASN.2020081150	journal	February 2021
Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects Flamme, Ingo; Oehme, Felix; Ellinghaus, Peter PLoS ONE, Vol. 9, Issue 11 https://doi.org/10.1371/journal.pone.0111838	journal	November 2014
Hypoxia Inducible Factor (HIF) transcription factor family expansion, diversification, divergence and selection in eukaryotes Graham, Allie M.; Presnell, Jason S. PLOS ONE, Vol. 12, Issue 6 https://doi.org/10.1371/journal.pone.0179545	journal	June 2017
HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism Haase, Volker H. Hemodialysis International, Vol. 21 https://doi.org/10.1111/hdi.12567	journal	April 2017
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents Haase, Volker H.; Chertow, Glenn M.; Block, Geoffrey A. Nephrology Dialysis Transplantation, Vol. 34, Issue 1 https://doi.org/10.1093/ndt/gfy055	journal	April 2018
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review Hirota, Kiichi Biomedicines, Vol. 9, Issue 5 https://doi.org/10.3390/biomedicines9050468	journal	April 2021
Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia Holdstock, Louis; Meadowcroft, Amy M.; Maier, Rayma Journal of the American Society of Nephrology, Vol. 27, Issue 4 https://doi.org/10.1681/ASN.2014111139	journal	October 2015
HIFalpha Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing Ivan, M.; Kondo, K.; Yang, H. Science, Vol. 292, Issue 5516 https://doi.org/10.1126/science.1059817	journal	April 2001
Targeting of HIF-alpha to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation Jaakkola, P.; Mole, D. R.; Tian, Y. -M. Science, Vol. 292, Issue 5516 https://doi.org/10.1126/science.1059796	journal	April 2001
Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates Koivunen, Peppi; Hirsilä, Maija; Remes, Anne M. Journal of Biological Chemistry, Vol. 282, Issue 7 https://doi.org/10.1074/jbc.M610415200	journal	February 2007
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. Lacombe, C.; Da Silva, J. L.; Bruneval, P. Journal of Clinical Investigation, Vol. 81, Issue 2 https://doi.org/10.1172/JCI113363	journal	February 1988
MammalianEGLNgenes have distinct patterns of mRNA expression and regulation Lieb, Mark E.; Menzies, Keon; Moschella, Maria C. Biochemistry and Cell Biology, Vol. 80, Issue 4 https://doi.org/10.1139/o02-115	journal	August 2002
Turn me on: regulating HIF transcriptional activity Lisy, K.; Peet, D. J. Cell Death & Differentiation, Vol. 15, Issue 4 https://doi.org/10.1038/sj.cdd.4402315	journal	January 2008
Vadadustat: First Approval Markham, Anthony Drugs, Vol. 80, Issue 13 https://doi.org/10.1007/s40265-020-01383-z	journal	August 2020
Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease Martin, Edouard R.; Smith, Mark T.; Maroni, Bradley J. American Journal of Nephrology, Vol. 45, Issue 5 https://doi.org/10.1159/000464476	journal	January 2017
Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing Metzen, Eric; Berchner-Pfannschmidt, Utta; Stengel, Petra Journal of Cell Science, Vol. 116, Issue 7 https://doi.org/10.1242/jcs.00318	journal	April 2003
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure Minamishima, Yoji Andrew; Moslehi, Javid; Bardeesy, Nabeel Blood, Vol. 111, Issue 6 https://doi.org/10.1182/blood-2007-10-117812	journal	March 2008
Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients Nangaku, Masaomi; Farag, Youssef M. K.; deGoma, Emil Nephrology Dialysis Transplantation, Vol. 36, Issue 7 https://doi.org/10.1093/ndt/gfaa060	journal	July 2020
Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan Nangaku, Masaomi; Kondo, Kazuoki; Takabe, Souichirou Therapeutic Apheresis and Dialysis, Vol. 25, Issue 5 https://doi.org/10.1111/1744-9987.13611	journal	December 2020
Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice Pan, Xiaoqing; Suzuki, Norio; Hirano, Ikuo PLoS ONE, Vol. 6, Issue 10 https://doi.org/10.1371/journal.pone.0025839	journal	October 2011
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease Pergola, Pablo E.; Spinowitz, Bruce S.; Hartman, Charlotte S. Kidney International, Vol. 90, Issue 5 https://doi.org/10.1016/j.kint.2016.07.019	journal	November 2016
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD Provenzano, Robert; Szczech, Lynda; Leong, Robert Clinical Journal of the American Society of Nephrology, Vol. 16, Issue 8 https://doi.org/10.2215/CJN.16191020	journal	August 2021
Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses Rabinowitz, Michael H. Journal of Medicinal Chemistry, Vol. 56, Issue 23 https://doi.org/10.1021/jm400386j	journal	August 2013
Divergent regulation of vascular endothelial growth factor and of erythropoietin gene expression in vivo Sandner, Peter; Gess, Bernhard; Wolf, Konrad Pflügers Archiv European Journal of Physiology, Vol. 431, Issue 6 https://doi.org/10.1007/s004240050084	journal	June 1996
Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience Sanghani, Neil S.; Haase, Volker H. Advances in Chronic Kidney Disease, Vol. 26, Issue 4 https://doi.org/10.1053/j.ackd.2019.04.004	journal	July 2019
Mechanisms of hypoxia signalling: new implications for nephrology Schödel, Johannes; Ratcliffe, Peter J. Nature Reviews Nephrology, Vol. 15, Issue 10 https://doi.org/10.1038/s41581-019-0182-z	journal	September 2019
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Semenza, G. L.; Wang, G. L. Molecular and Cellular Biology, Vol. 12, Issue 12 https://doi.org/10.1128/MCB.12.12.5447	journal	December 1992
HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress Singh, Rashim Pal; Franke, Kristin; Kalucka, Joanna Blood, Vol. 121, Issue 26 https://doi.org/10.1182/blood-2012-12-471185	journal	June 2013
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis Singh, Ajay K.; Carroll, Kevin; McMurray, John J. V. New England Journal of Medicine, Vol. 385, Issue 25 https://doi.org/10.1056/NEJMoa2113380	journal	December 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis Singh, Ajay K.; Carroll, Kevin; Perkovic, Vlado New England Journal of Medicine, Vol. 385, Issue 25 https://doi.org/10.1056/NEJMoa2113379	journal	December 2021
Plasticity of Renal Erythropoietin-Producing Cells Governs Fibrosis Souma, Tomokazu; Yamazaki, Shun; Moriguchi, Takashi Journal of the American Society of Nephrology, Vol. 24, Issue 10 https://doi.org/10.1681/ASN.2013010030	journal	July 2013
Epigenetic Silencing of Erythropoietin in Human Cancers Steinmann, K.; Richter, A. M.; Dammann, R. H. Genes & Cancer, Vol. 2, Issue 1 https://doi.org/10.1177/1947601911405043	journal	January 2011
Hypoxia-Inducible Factor and Oxygen Biology in the Kidney Sugahara, Mai; Tanaka, Tetsuhiro; Nangaku, Masaomi Kidney360, Vol. 1, Issue 9 https://doi.org/10.34067/KID.0001302020	journal	July 2020
Tissue-based map of the human proteome Uhlen, M.; Fagerberg, L.; Hallstrom, B. M. Science, Vol. 347, Issue 6220 https://doi.org/10.1126/science.1260419	journal	January 2015
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Wang, G. L.; Jiang, B. H.; Rue, E. A. Proceedings of the National Academy of Sciences, Vol. 92, Issue 12 https://doi.org/10.1073/pnas.92.12.5510	journal	June 1995
Integration of Oxygen Signaling at the Consensus HRE Wenger, Roland H.; Stiehl, Daniel P.; Camenisch, Gieri Science's STKE, Vol. 2005, Issue 306 https://doi.org/10.1126/stke.3062005re12	journal	October 2005
Effect of Human Erythropoietin Derived from Recombinant dna on the Anaemia of Patients Maintained by Chronic Haemodialysis Winearls, ChristopherG; Pippard, MartinJ; Downing, MichaelR The Lancet, Vol. 328, Issue 8517 https://doi.org/10.1016/S0140-6736(86)92192-6	journal	November 1986
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials Yeh, Tzu-Lan; Leissing, Thomas M.; Abboud, Martine I. Chem. Sci., Vol. 8, Issue 11 https://doi.org/10.1039/C7SC02103H	journal	January 2017
Structure, function, and activation of the erythropoietin receptor Youssoufian, H.; Longmore, G.; Neumann, D. Blood, Vol. 81, Issue 9 https://doi.org/10.1182/blood.V81.9.2223.2223	journal	May 1993

Similar Records

Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor

Journal Article · 2020 · J. Med. Chem. · OSTI ID:1834822

Lorthiois, Edwige; Roache, James; Barnes-Seeman, David; +52 more

A new anti-angiogenic small molecule, G0811, inhibits angiogenesis via targeting hypoxia inducible factor (HIF)-1α signal transduction

Journal Article · 2013 · Biochemical and Biophysical Research Communications · OSTI ID:22242191

Kim, Ki Hyun; Jung, Hye Jin

Allosteric inhibition of hypoxia inducible factor-2 with small molecules

Journal Article · 2013 · Nat. Chem. Biol. · OSTI ID:1073518

Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; +10 more

Open Access Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-In

Citation Formats

References (55)

Similar Records

Related Subjects